Ibm Retirement Fund Horizon Therapeutics Public LTD CO Transaction History

Ibm Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$79.4 - $116.36 $276,470 - $405,165	-3,482 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$86.42 - $109.81 $12,963 - $16,471	-150 Reduced 4.13%	3,482 $366,000
Q4 2021 Jan 19, 2022	SELL	$98.56 - $119.91 $251,229 - $305,650	-2,549 Reduced 41.24%	3,632 $391,000
Q2 2021 Jul 12, 2021	SELL	$86.24 - $95.92 $42,861 - $47,672	-497 Reduced 7.44%	6,181 $579,000
Q1 2021 Apr 22, 2021	SELL	$71.83 - $95.48 $38,931 - $51,750	-542 Reduced 7.51%	6,678 $615,000
Q4 2020 Jan 25, 2021	BUY	$67.0 - $84.39 $62,913 - $79,242	939 Added 14.95%	7,220 $528,000
Q3 2020 Oct 16, 2020	BUY	$55.23 - $79.93 $109,852 - $158,980	1,989 Added 46.34%	6,281 $488,000
Q2 2020 Jul 08, 2020	BUY	$30.2 - $56.98 $129,618 - $244,558	4,292 New	4,292 $239,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.